Zuluita, Shairah M.
HRN: 22-35-06 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/02/2024
CEFTRIAXONE 1G (VIAL)
03/02/2024
03/08/2024
IV
1g
OD
PCAP C; Acute Symptomatic Seizure
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes